Quince Therapeutics, Inc. , a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, announced that it will host an investor ...

The odds of developing systemic lupus erythematosus or systemic sclerosis appear to significantly increase with the use of ...

A number of young children with tuberous sclerosis complex who present with focal seizures or epileptic spasms at onset later develop intractable seizures with multifocal EEG abnormalities ...

in Ireland for the treatment of adult patients with relapsing multiple sclerosis (RMS) with active disease.1 BRIUMVI® is a novel monoclonal antibody that targets a unique epitope on CD20-expressing ...

Natco Pharma Ltd on Thursday said it has received approval from the US health regulator for its generic version of Everolimus tablets for oral suspension indicated for patients with tuberous sclerosis ...

Breckenridge Pharmaceutical, Inc., -the U.S. subsidiary of Towa International that markets, distributes, and sells generic pharmaceuticals in the United States, - announced today that the Food and ...

Multiple sclerosis (MS) is one of the most widespread disabling neurological conditions of young adults around the world. It affects almost 1 million people in the United States, and about 2.9 ...

Researchers don’t yet fully understand what causes multiple sclerosis (MS) but believe it may develop from a combination of genetic and environmental factors. Identifying these factors can help ...

Department of Neurology, Neurological Diagnosis and Treatment Center, Jinan Third People’s Hospital, Jinan, China Background: Ofatumumab, a fully human monoclonal antibody targeting CD20, is approved ...

Background: Tuberous sclerosis complex (TSC) is a multisystem genetic disorder primarily characterized by the development of benign tumors in multiple organs. While cardiovascular involvement is less ...

During his departure announcement in 2024, Neil thanked his bosses for their patience when he took off “a day or two here and there battling everything from multiple sclerosis and COVID to ...